Nedosiran sodium

(Synonyms: DCR-PHXC sodium)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Nedosiran (DCR-PHXC) sodium is an RNA interference (RNAi) targeting lactate dehydrogenase (LDH). Nedosiran sodium represents an impactful potential therapeutic for primary hyperoxaluria (PH) with end-stage renal disease (ESRD). Nedosiran sodium is a GalNAc-dsRNA conjugate.

For research use only. We do not sell to patients.

  • Purity: 92.35%
  • CAS No.: 2247026-22-6
  • Formula: C662H865F19N231O413P57S6.xNa
  • Molecular Weight:20985 (free acid)
  • Storage:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Nedosiran sodium

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00